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ABSTRAK
Tujuan: mendapatkan proporsi frailty (kerentaan), insidens major adverse cardiovascular events (MACE) 
30 hari dan mengkaji peran frailty terhadap prognosis pasien usia lanjut dengan penyakit jantung  koroner yang 
menjalani PCI elektif. Metode: studi kohort prospektif dilakukan untuk menilai kondisi frailty pasien usia lanjut 
dengan penyakit jantung koroner yang menjalani PCI elektif di RS Cipto Mangunkusumo dengan menggunakan 
kriteria frailty fenotipe. Pasien kemudian di follow-up selama 30 hari setelah tindakan PCI elektif untuk melihat 
apakah MACE terjadi atau tidak. Hasil: terdapat 100 pasien usia lanjut dengan penyakit jantung koroner yang 
menjalani PCI elektif dari bulan September 2014 - Juni 2015. Usia rerata pasien adalah 66,95 tahun (SD 4,875) 
dengan pasien terbanyak adalah laki-laki (69%). Sebanyak 61% pasien termasuk ke dalam kelompok frail. MACE 
terjadi pada 8,19% pasien pada kelompok frail dan 5,12% pada kelompok non-frail. Hubungan frailty terhadap 
MACE dapat dilihat pada hasil crude Hazard Ratio (HR) 1,6 (IK 95% 0,31-8,24). Pada penelitian ini, kesintasan 
30 hari 95% pada kelompok frail, sementara pada kelompok non-frail kesintasan 30 hari adalah sebesar 98%. 
Kesimpulan: terdapat peningkatan risiko 1,6 kali untuk terjadinya MACE 30 hari pada subyek usia lanjut frail 
yang menjalani PCI elektif namun belum bermakna secara statistik.
Kata kunci: frailty, major adverse cardiac events, penyakit jantung koroner, percutaneous coronary 
interventions, usia lanjut.
ABSTRACT
Aim: to obtain the proportion of frailty and the incidence of 30-day major adverse cardiovascular events 
(MACE) as well as to review the impact of frailty on the prognosis of elderly patients with coronary heart disease 
who underwent elective PCI. Methods: this is a prospective cohort study to assess the frailty of elderly patients 
with coronary artery disease that underwent elective PCI in Cipto Mangunkusumo Hospital using the frailty 
phenotype criteria. They were subsequently followed-up for 30 days to see whether there was any MACE developed. 
Results: there were 100 elderly patients with coronary artery disease who underwent elective PCI between September 
2014 and June 2015. The mean age of patients was 66.95 (SD 4.875) years and 69% of the patients were males. 
Frailty was present in 61% of the patients. MACE were occurred in 8.19% of frail patients and 5.12% were occurred 
in non-frail patients. The association between frailty and MACE was demonstrated by the result of crude HR of 1.6 
(CI 95% 0.31-8.24). In our study, the 30-day survival rate was 95% in frail patients and 98% in non-frail patients. 
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INTRODUCTION
According to the World Health Organization 
(WHO), cardiovascular disease is the number 
one cause of death in the world.1,2 A total of 17.3 
million people die annually from heart disease. 
Of all these deaths, 7.3 million people die due 
to coronary heart disease (CHD). In Indonesia, 
the incidence of heart disease in population 
aged over 15 years is 9.2% and about 4.8% of 
them have symptoms leading to angina pectoris. 
In addition, life expectancy in Indonesia is 
increasing every year. With the increasing 
number of aging population, the incidence of 
CHD is also increasing with age.2
In the past half decade, a number of studies 
conducted in New York have reported that the 
mortality rate of Major Adverse Cardiac Events 
(MACE) at the age of 60-80 years and over 80 
years is 4.1% and 11.5%, which is far higher 
than those with age less than 60 years old who 
has 1% mortality rate.3-5 Most of studies reported 
that there is an increased risk of vascular access 
complications as well as increased incidence 
of major bleeding on PCI procedure in elderly 
patients, which subsequently rising the mortality 
risk.5,6 Frailty itself is a physiological decline 
that could occur in every organ system, which 
is characterized by loss of function, loss of 
physiologic reserve, and increased susceptibility 
to disease and death.3 In several studies, 
frailty is often associated with elderly because 
frailty becomes more common with age.7 The 
prevalence of frailty in people aged 65 years 
and older is as much as 6.9%.8 Woodhouse et 
al8 specifically provide a definition that frail 
people are those  aged over 65 years who rely 
on others for daily activities and even under 
the supervision of the institution.9 There are 
differences regarding the definition of elderly 
between developed countries and developing 
countries. Most developing countries around the 
world, including Indonesia set a chronological 
age of 60 years to define the term “elderly”. 
While WHO has suggested the age of 65 years 
and over as a definition for elderly people in 
developed countries.10 There is a correlation 
between frailty and cardiovascular diseases, 
i.e. cardiovascular disease can accelerate the 
development of frailty. Frailty occurs in 25-50% 
of patients with cardiovascular disease depending 
on the measurement scale of frailty that being 
used. Frail patients with cardiovascular disease, 
especially those undergoing invasive methods 
such as PCI are more likely have more adverse 
effects than people without frailty.11-13
Until now, there are only two studies that 
have been published about the effect of frailty 
in patients undergoing PCI.14,15 Both studies 
were conducted at the same health center, Mayo 
Clinic, a tertiary health care center in Rochester, 
Minnesota and Franciscan Skemp Hospital in La 
Crosse, Wisconsin. Gharacholou et al15 conduct a 
study assessing the incidence of MACE (death, 
myocardial infarction, and re-revascularization) 
in patients undergoing PCI within 30 days 
and they reveal that the incidences of death, 
myocardial infarction, and re-revascularization 
in 30 days of frail patients are  0.8%, 6% and 
5%, respectively. Moreover, Sigh et al14 perform 
a study assessing the incidence of MACE 
(death and myocardial infarction) in patients 
aged 65 years over a period of 35 months. They 
demonstrate that there are 12% of patients have 
died, 11% has experienced non-fatal myocardial 
infarction and 22% have died or have myocardial 
infarction. Upon further analysis, they also reveal 
that during 3-year follow up, the mortality of 
patients with frail is 28% and it is 6% in non-frail 
patients. Frail patients are more likely having 
4-fold risk of death and 2.5-fold risk for having 
myocardial infarction. The study was conducted 
at Mayo Clinic with patients aged over 65 
years. It included in definition of elderly age for 
developed countries. Furthermore, another study 
Conclusion: there is a 1.6-fold increased risk of 30-day MACE in elderly frail patients undergoing elective PCI; 
however, it is not statistically significant.
Keywords: frailty, major adverse cardiac events, coronary artery disease, percutaneous coronary interventions, 
elderly.
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has been conducted at the Division of Cardiology 
in Cipto Mangunkusumo Hospital (RSCM), 
the national referral hospitals in Indonesia. The 
study was carried out in 2011 and included 510 
PCI procedures and 224 of them were performed 
in elderly patients (>60 years). There were 
approximately 513 PCI procedure had been 
conducted in RSCM for the last 3 years.
Although studies on the association between 
frailty and MACE following PCI procedure have 
been performed in other countries, but there 
are differences in population, epidemiology, 
comorbidites and hospital technologies between 
developed and developing countries, including 
Indonesia. Therefore, it becomes the basic reason 
to perform our study.
METHODS
Our study used an observational method 
with a prospective cohort design to evaluate 
the association between frailty and MACE. 
Moreover, our study has also been approved for 
ethics review issued by University of Indonesia 
on October 19, 2015, number 945 / UN2.F1/ 
ETHICS / X / 2015.
The study was conducted at  Cipto 
Mangunkusumo Hospital, Jakarta. Data sampling 
was carried out for 8 months, i.e. from October 
2014 until June 2015. General population for 
the study was an elderly group of patients who 
underwent elective PCI. The target population 
was elderly patients who had undergone the 
procedure at Cipto Mangunkusumo Hospital, 
Jakarta. The eligible population was selected as 
samples using exclusion and inclusion criteria.
By estimating the magnitude of α (type I 
error) as 5% and the power for the study (β-1) as 
80%, we calculated that the minimal sample size 
required for our study was 100 subjects.
The inclusion criteria for our study were all 
patients aged over 60 years old who had been 
diagnosed with coronary heart disease who had 
undergone elective PCI at Cipto Mangunkusumo 
Hospital, Jakarta. Moreover, the exclusion criteria 
were: 1) Post-stroke patient with persistent 
neurological deficit, severe Parkinson or dementia; 
2) patient who had difficulties to communicate and 
any lack of clinical information to determine the 
frailty of the patient; 3) patients with disabilities 
e.g unable to walk; 4) patient who rejected to 
participate in the study.
Data was obtained through history taking 
and direct physical examination after the patients 
had given their written informed consent. The 
criteria to evaluate the frailty phenotype such 
as hand grip strength were evaluated by Natong 
Hand Dynamometer using the dominant hand. 
Subseqeuntly, another criterion of phenotype 
frailty such as delayed walking was measured 
by asking the patient to walk 6 meters, which 
then observer could measure the velocity using a 
stopwatch in seconds. The frailty was evaluated 
by the investigators prior to the elective PCI 
procedure and the follow-up was carried out for 
30 days following the elective PCI.
Data obtained from history taking dan 
direct physical examination was tabulated and 
statistically analyzed using program SPSS 
version 21 and it was then presented using 
diagram. Data such as subject characteristics of 
socio-demographic, anthropometric and clinical 
diagnosis were presented by using descriptive 
statistics. Numeric data was presented as mean/
median value including the standard deviation. 
Nominal data was translated as proportion and 
confidence interval.
Statistical Analysis
Bivariate analysis was used to obtain data 
about the effect of frailty on MACE. The data 
was presented as different survival rate of 
developing MACE in elderly patients, both in 
frail and non-frail patients, which was described 
in Kaplan-Meier curve using Log-Rank test. 
Multivariate analysis was carried to adjust 
the confounding factors using the  analysis of 
Proportional Hazard Regression Model. With 
such analysis, the effect of frailty on MACE was 
presented as the adjusted hazard ratio and 95% 
confidence interval.
Each subject (or their family) received both 
direct and written explanation about the aim, 
procedures and advantages of our study. The 
subject was then asked for their written consent 
to participate in the study. All data obtained from 
the history taking and medical records used in 
our study were strictly confidential.
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RESULTS
In our study, the data of patients treated in 
Cipto Mangunkusumo Hospital was accumulated 
from September 2014 until June 2015. Within the 
period of study, 165 patients were treated with 
a primary diagnosis of coronary heart disease 
(CHD). About 31 patients could not have PCI 
procedure because there was no indication and 
the remaining 34 patients had not undergone 
the procedure since more time was needed for 
further examination of any underlying disease 
as well as preparing additional equipment 
for revascularization procedure, which could 
probably performed during the surgery. As many 
as 100 patients who met the inclusion criteria 
were recruited as the study subjects and they were 
followed up to 30 days following the elective PCI 
procedure. There was no subjects drop out.
Within the study period, we found that most 
subjects were male (69%) with an average age 
of 66.95 years (SD 4.875). From the sample 
population, we found that most had an education 
level that was equal to high school (37%) and 
undergraduates (31%) with an occupation as 
retired civil employee. Using the BMI criteria, 
44% of the sample population was overweight, 
28% was obese, 26% was normal and 2% was 
underweight.
Furthermore, we also found the following 
underlying disease, i.e. hypertension (80%) 
type II diabetes mellitus (54%), congestive 
heart failure (51%), chronic liver disease 
(6%), dyslipidemia (24%), cataract (4%) and 
arrhythmia (17%). Based on the medication 
use, we found that most subjects often used 
statin (79%), combined-dose of aspirin and 
clopidogrel (71%), and beta-blockers (58%). 
Other medications that had also been used were 
nitrates (32%), ACE Inhibitor (29%), ARB 
(25%), CCB (18%), aspirin (12%), clopidogrel 
(8%), and diuretics (6%)
In our study, the frailty was evaluated using 
frailty phenotype criteria. The criteria contained 
4 out of 5 objective (measureable) items that had 
been extensively validated to predict the health 
outcomes. Those items were shrinkage (25 
subjects), debility (49 subjects), lack of energy and 
endurance (35 subjects), tardiness (40 subjects) 
and poor physical activities (13 subjects).
The phenotype frailty criteria categorized 
the subjects into 3 group i.e. non-frail, pre-frail 
and frail groups. Considering the small sample 
size and limited amount of time in our study, 
we only categorized the subjects into the non-
frail and frail groups in order to optimize data 
analysis. There were 61 elderly patients (61%) 
with coronary heart disease undergoing elective 
PCI procdure with phenotype frailty score of 
≥3 in the frail group; while 39 patients (39%) 
with score of 0-2 were included in the non-frail 
group. The subject characteristics are presented 
in the Table 1.
In our study, the incidence of MACE in 
elderly patients with coronary heart disease 
underwent elective PCI procedure was 8.19% in 
the frail group and 5.12% in the non-frail groups. 
The MACEs were 1 event of death, 1 event of 
re-stenosis, 4 events of myocardium infarct and 
1 event of stroke. The Kaplan Meier test showed 
insignificant result, i.e. 0.57 (p Log Rank >0.05). 
Based on the results, we could identify that in 
the first seven days, non-frail patients had a 
survival rate of 98%; while the frail patient had 
97% survival rate. On the 14th day,the patients in 
non-frail group had a survival rate of 98%, while 
those in frail group had 96%. On the 21st day, 
the non-frail patients had 98% survival rate and 
the frail group had 95% survival rate.
In the non-frail group, 2 patients had MACE 
and 37 patients did not have MACE; while in the 
frail group, 5 patients experienced MACE and 56 
patients did not experience MACE. The effect of 
frailty on MACE can be seen based on the crude 
HR, which was 1.6 (CI 95% 0.31-8.24).The data 
shown here indicates that the frailty increases 
the risk for MACE as much as 1.6 times higher.
DISCUSSION
Our study is a retrospective cohort study, 
which was conducted in 100 elderly patients with 
CHD who underwent elective PCI procedure 
at Cipto Mangunkusumo Hospital between 
September 2014 and June 2015.
Our study showed that there was a greater 
proportion of male (69%) than female subject 
(31%). We recorded that 55.07% male subjects 
and 74.2% female subjects undergoing elective 
PCI procedure were frail patients. The tendency 
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Tabel 1. Characteristics of subjects
Variables Overall population (n=100) Non-Frail (n=39) Frail (n=61)
Sex, n (%)
 - Male 69 (69) 31 (79) 38 (62.3)
 - Female 31 (31) 8 (20.5) 23 (37.7)
Range of age, n (%)
 - 60-69 years old 75 (75) 29 (74.3) 46 (75.4)
 - 70-79 years old 25 (25) 10 (25.7) 15 (24.6)
Education, n (%)
 - Post bachelor 5 (5) 3 (7.7) 2 (3.3)
 - Bachelor 31 (31) 9 (23.1) 22 (36.1)
 - Vocation 6 (6) 2 (5.1) 4 (6.5)
 - High-school 37 (37) 15 (38.5) 22 (36.1)
 - Middle high 10 (10) 5 (12.8) 5 (8.2)
 - Elementary 11 (11) 5 (12.8) 6 (9.8)
Jobs n (%)
 - Housewives 14 (14) 4 (10.2) 10 (16.4)
 - Retired civil employees 32 (32) 7 (18) 25 (41)
 - Retired private employees 15 (15) 10 (25.6) 5 (8.2)
 - Enterpreneurs 14 (14) 3 (7.7) 11 (18)
 - Others 24 (24) 14 (35.9) 10 (16.4)
 - Unemployed 1 (1) 1 (2.6) 0 (0)
IMT, n (%)
 - Underweight (<18.5) 2 (2) 1 (2.6) 1 (1.7)
 - Normal (18.5-22.9) 26 (26) 13 (33.3) 13 (21.3)
 - Overweight (23-27.4) 44 (44) 15 (38.5) 29 (47.5)
 - Obese (>27.5) 28 (28) 10 (25.6) 18 (29.5)
Comorbid diagnosis, n (%)
 - Hypertension 80 (80) 30 (76.9) 50 (81.9)
 - Type 2 diabetes mellitus 54 (54) 20 (51.3) 34 (55.7)
 - Congestive heart failure 51 (51) 19 (48.7) 32 (52.4)
 - Cerebrovascular disease 10 (10) 4 (10.2) 6 (9.8)
 - Chronic kidney disease 21 (21) 9 (23.1) 12 (19.7)
 - Chronic liver disease 6 (6) 1 (2.5) 5 (8.2)
 - Dyslipidemia 24 (24) 9 (23) 15 (24.6)
 - Cataracs 4 (4) 0 (0) 4 (6.5)
 - Arythmias 17 (17) 4 (10.2) 13 (21.3)
Medication, n (%)
 - Aspirin + Clopidrogel 71 (71) 26 (66.7) 45 (73.7)
 - Aspirin 12 (12) 6 (15.4) 6 (9.8)
 - Clopidrogel 8 (8) 3 (7.7) 5 (8.2)
 - Statin 79 (79) 28 (71.8) 51 (83.6)
 - Beta Blocker 58 (58) 23 (59) 35 (57.3)
 - ARB 25 (25) 12 (30.7) 13 (21.3)
 - CCB 18 (18) 4 (10.2) 14 (23)
 - Nitrat 32 (32) 7 (18) 25 (41)
 - ACE Inhibitor 29 (29) 12 (30.8) 17 (27.9)
 - Diuretics 6 (6) 3 (7.7) 3 (4.9)
Rachmat Hamonangan                                                                                                           Acta Med Indones-Indones J Intern Med
96
of women experiencing frailty had been studied 
by a large scale study conducted by Fried et al.16-
18 Female is often associated with intrinsic risk 
factors of frailty since  women have greater body 
mass and weaker than men of the same age. Thus, 
loss of body mass in women can cause frailty.18-20
The proportion of frail subjects in this study 
is 61%. The mean age of subjects was 66.95 years 
(SD 4.875) years. There were 75 subjects aged 
60-69 years, in which 46 (61.33%) of them were 
frail and 15 subjects out of 25 subjects aged 70-
79 year (60%) were frail. The mean age of frail 
subjects was 67.1 years compared to 66.8 years 
in the non-frail subjects. A study by Fried et al. 
that evaluated 5317 elderly subjects aged 65 – 
101 years found that the prevalence of frailty is 
6.9%. The study had three grops categorized by 
age, i.e. 3.2% of subjects were at 65-70 years, 
5.3% aged 71-74 years and there were 95% with 
75-79 years of age. The prevalence of frailty in 
the study was found greater than similar studies 
such as the study conducted by Murali-Krishnan 
(11% subjects with mean age of 61 (SD 12 years), 
Mandeep-Singh (18.6% subjects with mean age 
of 74.3 (SD 6.4) years.
The criteria that had been used in the 
study are the same with those in Mandeep-
Singh study; while Murali-Krishnan used the 
criteria of Canadian Study of Health and Aging 
Clinical Frailty Scale, which is simpler and 
more subjective. The discrepancy of frailty 
prevalence may be due to differences in subject 
characteristics and the study site. Frailty has been 
often associated with cardiovascular disease. 
Fried in his large-scale population study, the 
Cardiovascular Health Study, has also found that 
62% of frail subjects had cardiovascular disease 
and there were three-fold incidence of frailty in 
subjects with cardiovascular disease.19
The elderly frail subjects in our study 
had more comorbidities than the non-frail 
subjects. Approximately, frail subjects had 2.96 
comordities; while the non-frail subjects had 
2.46 comorbidities. Hypertension was found in 
81.9% frail subjects compared to 76.9% in the 
non-frail subjects. Similar conditions were also 
found in patients with type 2 diabetes mellitus 
(frail vs. non-frail: 55.7 vs. 51.3%), congestive 
heart failure (52.4% vs. 48.7%), cerebrovascular 
























Figure 1. Kaplan Meier chart the survival of elderly patient with coronary heart disease on PCI elective.
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(19.7% vs. 23.1 %) and arrhythmia (21.3% vs. 
10.2%). The result is consistent with several 
studies related to frailty and elderly patients who 
underwent PCI procedure.14,17,18
In our study, there were more frail subjects 
using combined medication than those in the 
non-frail group (4.52 vs. 3.76). It was associated 
with the number of comorbidities, which was 
indeed found greater in the frail subjects.
MACE might occur in long term and short 
term. In our study, the incidence of 30-day 
MACE was evaluated by the investigator in order 
to identify the shor-term incidence, i.e. during 
hospitalization (in-hospital MACE) and during 
the ambulatory care in the outpatient clinic in 
patients had been followed-up for 30 days. The 
overall MACE incidence was 7%. The MACE 
incidence included 1 event of death, 1 event of 
restenosis, 4 events of myocardium infarct and 
1 event of stroke. In the frail group, the 30-day 
MACE was 8.19%; while in the non-frail group 
the incidence was approximately 5.12%.
Furthermore, four of seven MACEs were 
the in-hospital MACEs. Overall, there was only 
one death event; therefore, the mortality rate in 
one-month period was 1%. The rate found in 
our study is higher than other available studies. 
The Multi-Kharisnan study demonstrated that 
the 30-day mortality was 1.5% for all subjects. 
When they categorized the subjects into groups, 
the mortality rate of frail group was 4.9% and 
the non-frail group was 1.1%. According to 
the Murali-Kharisnan study, frail patients have 
5-fold greater risk of death in 30-days after 
PCI than the non-frail patients. Lo et al.20 who 
studied 54 elderly patients aged over 80 years 
who underwent PCI procedure showed that there 
was 1.9% MACE in one month. There was no 
in-hospital mortality within a month.
Gharacholou14 performed a study in 629 
elderly patients aged 65 years or older who 
underwent PCI and showed that there was 
18.6% proportion of frailty and the mortality 
or myocardium infarct occurred within 30 days 
was 6%. Moreover, even when the short-term 
MACE included mortality, myocardium infarct 
and revascularization, the 30-day MACE was 
9%. The high rate of MACE found in the study 
may occur since Gharacholou did not only 
include elective PCI for inclusion criteria; while 
in our study, we only included the elective PCI 
procedure in our inclusion criteria.20
In our study, three patients who experienced 
MACE were at the age less than 70 years; while 
the remaining 4 patients aged more than 70 years. 
Most patients had two or more comorbidities, 
whereas five patients had three or more. Patients 
who experienced MACE also had high body 
mass index (overweight or obese).
The multivariate analysis showed that the 
crude HR was 1.6 for the variable of frailty 
against MACE in elderly patients with CHD, 
meaning that the subjects with frailty had 1.6-
fold greater risk for MACE within 30 days than 
those in the non-frail group. The number was 
smaller than those in Murali-Kharisnan study, 
which found HR of 4.8 (95% CI 1.4 to 16.3) 
for mortality in frail subjects undergoing PCI 
procedure.20
Multivariate analysis was performed for 
frailty and confounding variables with p<0.25; 
therefore, the adjusted HR of frailty against 
MACE was found. After an adjustment was made 
gradually for other variables affecting MACE 
including hypertension and arrhythmia, we found 
that the adjusted HR was 1.5 (95% CI 0.29-7.71).
In our study, the incidence of 30-day 
MACE in elderly patients with coronary heart 
disease who underwent elective Percutaneous 
Coronary Intervention was not significant since 
the restenosis or progression of disease  rarely 
occurs within 1 month period; therefore, it can 
be concluded that the complication that develops 
within 1 month following the PCI is more 
correlated to the procedure or patient selection.21
The limitation of our study is that the study 
was only conducted at one hospital; thus, 
the obtained subject characteristics were the 
characteristic of elderly patients who sought 
treatment at the hospital. The number of sample 
size is relatively small since it was based on the 
assumed number of hazard ratio used in the study. 
Our study also did not compare the results with 
younger age population.
In previous studies, subjects were categorized 
into the non-frail, pre-frail and frail group. Such 
categories enable investigators to perform 
analysis on study subjects. In our study, the non-
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frail and pre-frail group were included into the 
non-frail group.
CONCLUSION
The proportion of frailty in elderly subjects 
with coronary heart disease undergoing elective 
PCI procedure is 61%. The incidence of 
30-day MACE in frail elderly patients with 
coronary heart disease following the elective PCI 
procedure is 8.19%; while in the non-frail group, 
the incidence is 5.12%. Elderly frail patients 
with coronary heart disease undergoing the PCI 
procedure have a high risk - 1.6 times more than 
the non-frail group - in experiencing MACE.
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